When targeting cancer genes, zero in on the 1 percent

Jamie Cate and fellow UC Berkeley researchers have now found a promising new drug target within that pathway that is appealing, in part, because it appears to control production of only a few percent of the body’s many proteins, those critical to regulating the growth and proliferation of cells. Read the article.(link is external)